Individuals with COPD and frailty have increased risk of dyspnea and exacerbations: Study
A new study published in the journal of BMC Pulmonary Medicine showed that dyspnea (mMRC score 1.67), symptom load (CAT score 10.24), and exacerbations were considerably greater in frail patients with chronic obstructive pulmonary disease (COPD).
Frailty is a multifaceted condition marked by a build-up of physiological deficiencies that lead to a loss of functional, cognitive, and physical reserves. A person is more susceptible to health stresses, including falls, hospital stays, and acute flare-ups of chronic illnesses, when frailty is present and worsens.
Despite the underlying causes of frailty are many, they share characteristics with those of COPD, including endocrine dysregulation, decreased muscle mass and function, and chronic systemic inflammation. To learn more about the relationship between frailty and clinical outcomes for individuals with COPD, Mathew Cherian and team conducted a systematic review and meta-analysis of the literature.
This study reviewed MEDLINE, Cochrane Central, EMBASE, CINAHL, and Web of Science for observational studies assessing the relationship between frailty and clinical outcomes in people with COPD. The included studies evaluated dyspnea, symptom load, health-related quality of life, exacerbations, hospitalization, or death between frail and non-frail patients, diagnosed COPD by spirometry, and employed a validated frailty assessment instrument.
7 of the 16 studies which represented a total of 5903 individuals were included in the meta-analyses out of the 1,385 identified studies. 50% of the included studies employed the Fried Frailty Phenotype assessment. Pooled estimates showed that frail individuals with COPD experienced increased dyspnea ratings, a greater burden of symptoms, and more COPD exacerbations during the previous year when compared to non-frail individuals. Frail vs. non-frail COPD patients had a higher mortality risk, according to the biggest research with the longest follow-up duration.
Overall, the patients who are frail have higher rates of hospitalizations, exacerbations, symptom load, and dyspnea when compared to COPD patients who are not weak. Frailty should be seen as a therapeutic feature because it is a strong predictor of outcomes for individuals with COPD.
Reference:
Cherian, M., Masoudian, P., Thavorn, K., Sandoz, J., Shorr, R., & Mulpuru, S. (2025). The impact of frailty on clinical outcomes among individuals with COPD: a systematic review and meta-analysis. BMC Pulmonary Medicine, 25(1), 146. https://doi.org/10.1186/s12890-025-03595-z
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.